At Glochem we are focused on maintaining our current strong position in Amlodipine, Cetirizine and Levo Ceririzine and expanding our market reach further across the globe. We will continue to work to gain similar leadership/strong positions for the other API's namely Raloxifine, Hydroxyzine HCL and Telmisartan, in a few years.

Our endeavor is to add 2 to 3 products every year to our business. We are in the process of introducing three more APIs Famotidine, Lercanidipine, Empagliflozin next year.

The company is also in the process of expanding the manufacturing capacities in the existing facility at Bollaram, Hyderabad besides buliding a new 10 acre greenfield facility at Kadechur, Karnataka.